Lifeway Foods, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LWAY research report →
Range $30 – $30
Price Chart
About the company
Lifeway Foods, Inc. manufactures and distributes a variety of probiotic-rich goods, serving both the United States and international markets. Its principal offering is drinkable kefir, a fermented dairy item available in numerous forms, including organic and conventional options, various volumes, flavors, and formulations such as reduced-fat, fat-free, whole milk, high-protein, and BioKefir.
- CEO
- Julie Smolyansky
- IPO
- 1988
- Employees
- 293
- HQ
- Morton Grove, IL, US
Get TickerSpark's AI analysis on LWAY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $289.63M
- P/E
- 38.43
- Fwd P/E
- 52.76
- PEG
- -1.24
- P/S
- 1.17
- P/B
- 3.45
- EV/EBITDA
- 19.54
- Div Yield
- 0.00%
- Gross Margin
- 22.88%
- Op Margin
- 4.65%
- Net Margin
- 3.00%
- ROE
- 8.78%
- ROIC
- 7.11%
Latest fiscal year · YoY change
- Revenue
- $212.50M+13.7%
- Gross Profit
- $58.21M+19.8%
- Op Income
- $16.17M
- Net Income
- $13.86M+53.6%
- EPS
- $0.91+49.2%
- OCF Growth
- -15.5%
- FCF Growth
- -362.0%
- 52W High
- $32.71
- 52W Low
- $17.31
- 50D MA
- $22.11
- 200D MA
- $24.50
- Beta
- 0.49
- RSI (14)
- 38
- Avg Volume
- 133.42K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Lifeway posted a record Q3 as sales growth stayed strong, but capacity constraints and higher input costs kept margins under pressure ahead of a 2027 expansion.· November 12, 2026
- Q3 net sales hit a company record of $67.8 million, marking the 28th straight quarter of year-over-year sales growth.
- Through the first 9 months, net sales were $197.7 million, up 25.8%, putting the company on pace to exceed its prior full-year record.
- Gross margin was 18% in Q3, weighed by higher milk, packaging and freight costs; management expects Q4 margin to sit between Q2 and Q3 levels.
- The Waukesha expansion is expected to begin increased production in Q1 2027 and more than double facility capacity when complete.
- Management said the company is on allocation with existing customers today, but believes 2027 should unlock significant distribution and volume growth.
Third quarter net sales were $67.8 million, the highest quarterly net sales in company history. That represented the 28th consecutive quarter of year-over-year net sales growth, and management said Q3 growth was nearly 19% despite a planned one-week Waukesha shutdown. Gross margin was 18% in Q3, pressured by an elevated input cost environment; milk prices rose approximately 26% in Q2 versus Q1 and eased only minimally in Q3, while oil prices lifted packaging and freight costs. Selling, general and administrative expenses were 16.2% of net sales versus 19.6% a year ago, and net income was $0.3 million, or $0.02 per basic and diluted share, versus $3.5 million, or $0.23 per share, last year. Year to date, net sales were $197.7 million, up 25.8%. For Q4, management expects gross margin to be between Q2 and Q3 levels, with price increases rolling in through the end of the year and into Q1 2027. They also said average milk cost should be higher in Q4 than Q3, and they expect gross margin expansion and improved profitability in 2027 as pricing and Waukesha efficiencies take hold.
Julie Smolyansky framed the quarter as proof that demand for Lifeway’s kefir and related products remains very strong, while stressing that the company is temporarily constrained by production capacity. She said the Waukesha expansion is a necessary investment that will more than double capacity, modernize operations, and support growth across the portfolio, including kefir, Farmer Cheese and newer items. Her tone was upbeat and confident, emphasizing that 2027 should not be a conversation about capacity and that the company has significant runway for shelf-space and distribution gains.
Eric Hanson did not provide separate prepared financial remarks in the transcript, but the call included specific financial commentary from management on margins and costs. Gross margin was 18% in Q3, SG&A was 16.2% of net sales versus 19.6% last year, and net income was $0.3 million versus $3.5 million a year ago. Management said milk prices were up about 26% in Q2 versus Q1 and remained elevated in Q3, with Q4 milk costs expected to be higher still; packaging ingredients and transportation costs are also expected to stay elevated. Pricing actions are set to roll through late 2026 and early 2027, and management expects gross margin to recover toward 25%+ in 2027 as pricing and capacity efficiencies are realized.
Analysts focused on how much of 2027 growth could come from relieving the current capacity constraint versus underlying demand. Management said the company is on allocation with existing customers, that capacity will remain tight in Q4 and slightly into Q1, and that Waukesha upgrades begin in January with the majority coming in February. Questions also centered on price increases and margin recovery; management said the last broad price increase was in 2022, that retailer discussions have been constructive, and that pricing plus Waukesha efficiencies could help the company return to historic margins of 25%+. They also confirmed that the expansion should support broader distribution, including at Costco DCs, and that 2027 should allow Lifeway to fulfill pent-up demand across kefir, Farmer Cheese and other products.
The bull case is that underlying demand appears strong enough to exceed current production, with management describing the company as on allocation and seeing broad interest from existing and potential customers. The Waukesha project is expected to more than double capacity in 2027, while price increases and operating efficiencies could restore margins toward 25%+.
The near-term bear case is that capacity limits are still constraining sales and will likely persist through Q4 and into early Q1 2027, so some demand is being left unfulfilled today. Margin pressure also remains significant, with Q3 gross margin at 18%, Q4 milk costs expected to rise further, and packaging and freight costs still elevated despite planned price increases.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 49.4%
- Shares Outstanding
- 15.11M
- Float Shares
- 7.47M
of shares held by institutions
99 13F filers
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Divisadero Street Capital Management, LP | 2.10M | ▲ 692.77K |
| Citadel Advisors LLC | 930.11K | ▲ 858.23K |
| Wellington Management Group Llp | 585.10K | ▲ 585.10K |
| Blackrock, Inc. | 569.20K | ▲ 247.02K |
| Vanguard Capital Management LLC | 407.86K | ▲ 41.09K |
| Renaissance Technologies LLC | 349.07K | ▼ 28.10K |
| Vanguard Group Inc | 343.04K | ▲ 31.10K |
| Pillsbury Lake Capital LLC | 299.44K | ▲ 7.73K |
| Awm Investment Company, Inc. | 264.22K | ▲ 41.22K |
| Dimensional Fund Advisors LP | 261.12K | ▲ 2.75K |
| Geode Capital Management, LLC | 237.23K | ▲ 79.00K |
| Two Sigma Investments, LP | 228.14K | ▲ 108.51K |
Held by 111 ETFs
Biggest fund positions in LWAY by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 12, 26 | SMOLYANSKY EDWARD | sell | 72,440 |
| Nov 12, 26 | SMOLYANSKY EDWARD | sell | 2,460 |
| Nov 12, 26 | SMOLYANSKY EDWARD | sell | 100 |
| Nov 13, 26 | SMOLYANSKY EDWARD | sell | 75,000 |
| Nov 12, 26 | SMOLYANSKY LUDMILA | sell | 20,000 |
| Nov 13, 26 | SMOLYANSKY LUDMILA | sell | 20,000 |
| Nov 4, 26 | SMOLYANSKY EDWARD | sell | 66,218 |
| Nov 4, 26 | SMOLYANSKY EDWARD | sell | 3,782 |
| Oct 13, 26 | SMOLYANSKY EDWARD | sell | 30,000 |
| Oct 6, 26 | Divisadero Street Capital Management, LP | buy | 50,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LWAY coverage
Recent articles, reports, and earnings notes.
No research on LWAY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LWAY report →Lifeway: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 13
Lifeway Foods Q3 Earnings Call Highlights
marketbeat.com · Nov 12
Lifeway Foods, Inc. (LWAY) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 12
Lifeway Foods® Reports Record High Quarterly Net Sales, Extends Kefir Category Leadership in Third Quarter 2026
prnewswire.com · Nov 12
Lifeway Foods (NASDAQ:LWAY) Stock: Insider Edward Smolyansky Sells 70,000 Shares
defenseworld.net · Nov 7
Lifeway® Kefir Commercial Makes Chicagoland Television Debut Sunday, November 8, With New Muscle Mates™ Social Media Campaign to Follow
prnewswire.com · Nov 6
Lifeway Foods® to Report Third Quarter 2026 Results on November 12, 2026
prnewswire.com · Oct 29
Lifeway® Foods Named to Fortune's 100 Fastest-Growing Companies List, Ranking No. 45 in 2026
gurufocus.com · Oct 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.